Abstract
An overview of the detection of benzodiazepines and their respective metabolites and target analytes in urine by LC-MS/MS is described. This overview shows substantial differences in the approach to detection using this technique including optional use of β-glucuronidase to hydrolyze conjugates present in urine. There are also significant variations in the extraction method employed from the use of direct injection, liquid-liquid extraction to solid-phase extraction options, with little apparent difference in limits of detection. Chromatography was largely based on the use of C18-bonded columns; however both C8- and phenyl-bonded columns were used to affect separation. Modern-day tandem mass spectrometers are capable of exceptional sensitivity enabling detection of sub-nanogram per milliliter amounts in urine, which provide for longer detection times in the urine of suspected drug-facilitated assaults. A method employed in the laboratory of the authors is provided by way of an example for readers wishing to establish a method in their own laboratory.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Sundstrom M, Pelander A, Angerer V, Hutter M, Kneisel S, Ojanpera I (2013) A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine. Anal Bioanal Chem 405(26):8463–8474
Anderson LJ, Flynn A, Pilgrim JL (2017) A global epidemiological perspective on the toxicology of drug-facilitated sexual assault: a systematic review. J Forensic Legal Med 47:46–54
ElSohly MA, Gul W, ElSohly KM, Avula B, Khan IA (2006) LC-MS-(TOF) analysis method for benzodiazepines in urine samples from alleged drug-facilitated sexual assault victims. J Anal Toxicol 30(8):524–538
Glover SJ, Allen KR Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay, pp 1758–1001 Electronic
Guale F, Shahreza S, Walterscheid JP et al (2013) Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens. J Anal Toxicol 37(1):17–24
Jagerdeo E, Schaff JE (2016) Rapid screening for drugs of abuse in biological fluids by ultra high performance liquid chromatography/Orbitrap mass spectrometry. J Chromatogr B 1027:11–18
Jeong Y-D, Kim MK, Suh SI, In MK, Kim JY, Paeng K-J (2015) Rapid determination of benzodiazepines, zolpidem and their metabolites in urine using direct injection liquid chromatography–tandem mass spectrometry. Forensic Sci Int 257:84–92
Karampela S, Vardakou I, Papoutsis I et al (2012) Direct urine analysis for the identification and quantification of selected benzodiazepines for toxicology screening. J Chromatogr B 902:42–46
Lee H-H, Lee J-F, Lin S-Y, Chen B-H (2016) Simultaneous identification of abused drugs, benzodiazepines, and new psychoactive substances in urine by liquid chromatography tandem mass spectrometry. Kaohsiung J Med Sci 32(3):118–127
Marin SJ, Coles R, Merrell M, McMillin GA (2008) Quantitation of benzodiazepines in urine, serum, plasma, and meconium by LC-MS-MS. J Anal Toxicol 32(7):491–498
Ming DS, Heathcote J (2011) A rapid and accurate UPLC/MS/MS method for the determination of benzodiazepines in human urine. J Chromatogr B 879(5):421–428
Pettersson Bergstrand M, Helander A, Beck O (2016) Development and application of a multi-component LC-MS/MS method for determination of designer benzodiazepines in urine. J Chromatogr B Analyt Technol Biomed Life Sci 1035:104–110
Remane D, Wetzel D, Peters FT (2014) Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for screening of urine specimens for 100 analytes relevant in drug-facilitated crime (DFC). Anal Bioanal Chem 406(18):4411–4424
Salomone A, Gerace E, Brizio P, Gennaro MC, Vincenti M (2011) A fast liquid chromatography-tandem mass spectrometry method for determining benzodiazepines and analogues in urine. Validation and application to real cases of forensic interest. J Pharm Biomed Anal 56(3):582–591
Schaefer N, Peters B, Schmidt P, Ewald AH Development and validation of two LC-MS/MS methods for the detection and quantification of amphetamines, designer amphetamines, benzoylecgonine, benzodiazepines, opiates, and opioids in urine using turbulent flow chromatography. Anal Bioanal Chem 405(1):247–258
Verplaetse R, Cuypers E, Tytgat J (2012) The evaluation of the applicability of a high pH mobile phase in ultrahigh performance liquid chromatography tandem mass spectrometry analysis of benzodiazepines and benzodiazepine-like hypnotics in urine and blood. J Chromatogr A 1249:147–154
Xiong L, Wang R, Liang C et al (2015) Determination of co-administrated opioids and benzodiazepines in urine using column-switching solid-phase extraction and liquid chromatography–tandem mass spectrometry. J Chromatogr A 1395:99–108
Mata DC, Davis JF, Figueroa AK, Stanford MJ (2016) Ultra performance liquid chromatography with tandem mass spectrometry for the quantitation of seventeen sedative hypnotics in six common toxicological matrices. J Anal Toxicol 40(1):58–63
Perez ER, Knapp JA, Horn CK, Stillman SL, Evans JE, Arfsten DP (2016) Comparison of LC-MS-MS and GC-MS analysis of benzodiazepine compounds included in the drug demand reduction urinalysis program. J Anal Toxicol 40(3):201–207
Rosano TG, Ohouo PY, Wood M (2017) Screening with quantification for 64 drugs and metabolites in human urine using UPLC-MS-MS analysis and a threshold accurate calibration. J Anal Toxicol:1–11
Tang MH, Ching CK, Lee CY, Lam YH, Mak TW (2014) Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by UHPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 969:272–284
Hegstad S, Hermansson S, Betner I, Spigset O, Falch BM (2014) Screening and quantitative determination of drugs of abuse in diluted urine by UPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 947-948:83–95
Hoiseth G, Tuv SS, Karinen R (2016) Blood concentrations of new designer benzodiazepines in forensic cases. Forensic Sci Int 268:35–38
Al-Saffar Y, Stephanson NN, Beck O (2013) Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci 930:112–120
Sturm S, Hammann F, Drewe J, Maurer HH, Scholer A (2010) An automated screening method for drugs and toxic compounds in human serum and urine using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878(28):2726–2732
Sundström M, Pelander A, Ojanpera I (2017) Comparison of post-targeted and pre-targeted urine drug screening by UHPLC-HR-QTOFMS. J Anal Toxicol
Sargent M (ed) (2013) Guide to achieving relaible quantitative LC-MS measurements, 1st edn. RSC Analytical Standards Committee, Cambridge
SWGTOX 2013 Scientific working group for forensic toxicology (SWGTOX) standard practices for method validation in forensic toxicology 20 May
Acknowledgments
The authors gratefully acknowledge the staff of the toxicology section of the Victorian Institute of Forensic Medicine, many of whom have contributed to the validation and use of the procedure outlined in this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Drummer, O.H., Di Rago, M., Gerostamoulos, D. (2019). Analysis of Benzodiazepines for Drug-Facilitated Assaults and Abuse Settings (Urine). In: Langman, L., Snozek, C. (eds) LC-MS in Drug Analysis. Methods in Molecular Biology, vol 1872. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8823-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8823-5_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8822-8
Online ISBN: 978-1-4939-8823-5
eBook Packages: Springer Protocols